Darine Ghanem: Shaping the Future of Hemophilia A Care Together at ISTH 2026
Darine Ghanem, Commercialisation Excellence Lead for Non-Malignant Hemathology at Roche, shared on LinkedIn:
“Every generation has the opportunity and the responsibility to leave hemophilia A care better than they found it.
As we gather at International Society on Thrombosis and Haemostasis (ISTH), I am inspired by how far our community has come and energized by what we can achieve together.
Scientific progress continues to redefine what is possible, but our ambition remains unchanged: to keep listening to the community, to keep learning, to keep innovating, and to continue elevating the standard of care for people living with hemophilia around the world.
Here for Generations. Here for Life. This is our enduring commitment to patients, families, healthcare professionals, and the broader hemophilia A community that we will continue to lead with purpose, advance innovation, and work together to create a better future.
I want to extend my sincere thanks to all our Roche teams across all affiliates and to our Pharma CEO Teresa Harris Graham and to our Head of Pharma International Padraic Ward for being with us at ISTH in Paris this year.
Your leadership, expertise, and unwavering commitment to the hemophilia A community are what make this progress possible. Every day, you bring our purpose to life through collaboration, scientific excellence, and an enduring focus on improving patients’ lives.
I am grateful to the conversations, learning, and partnerships that ISTH inspired. Together, we have the opportunity to shape the future of hemophilia A care for generations to come, and for life.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
-
Aug 13, 2026, 08:11Cristiana Coneru: How the Gut Microbiome Influences Venous Thrombosis
-
Aug 13, 2026, 06:36Steffen Uffenorde: Improving Access to Automated Red Cell Exchange in SCD